Please login to the form below
As Europe goes to polls, pharma seeks to keep healthcare, R&D a priority
Eurosceptics want to block greater EU integration
Latecomer Lilly preps its IL-23 drug for Crohn’s disease
Hopes to leapfrog rivals
Verily unveils next-gen trials alliance with Novartis, Pfizer
New data methods and tech will be used to streamline trials
Syncona launches another cell therapy company, Treg specialist Quell
Focuses on novel immune system approach
The Gallery
<>A visual showcase of agency work. Track down an agency from the image, track down your competitors' work, search by product or therapy area to pull up, for example, cardiovascular campaigns. Click here for a portfolio of hundreds of campaign visuals – updated regularly – free for you to reference. Agencies – to add your work to The Gallery please contact us.
Bluebird: on a mission to ‘recode’ the DNA of healthcare
Europe is the test ground for the gene therapy pioneer’s outcomes-based model, which could set the standard for the emerging sector
Health comms agency emotive hires new cell and gene therapy leader
New division will cater to fast-expanding field
An increasingly polarised world offers the opportunity for healthcare organisations to build trust by turning inwards
By Dr Eleanor Read
McCann Health bolsters European leadership team
New hires will deepen the agency’s capabilities in the healthcare market
Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader
Featured jobs
-
Midweight Brand Planner
-
Up to £50, 000
- Head of Partnerships - Competitive - London
-
Competitive Salary Offered
-
Senior Medical Writer
-
Salary TBC
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
Subscribe to our email news alerts
- Moving annual total (MAT)
- Grail’s multi-cancer blood test gets FDA breakthrough status
- Babylon expansion sparks ‘NHS destruction’ warnings
- Syncona launches another cell therapy company, Treg specialist Quell
- Spinraza managed access deal in England breaks deadlock for Biogen
- Positive mid-stage trial gives Allergy’s investors some welcome relief
- Latecomer Lilly preps its IL-23 drug for Crohn’s disease
- Merck bulks up in cancer with $2.2bn Peloton buy
- Transforming value and access outcomes in the Asia-Pacific region: a new market access study
- Verily unveils next-gen trials alliance with Novartis, Pfizer
- An increasingly polarised world offers the opportunity for healthcare organisations to build trust by turning inwards
- Focusing on patient-centricity to build trust in pharma
PMHub
Complete HealthVizion
Complete HealthVizion is a global team of fresh thinkers who aspire to be better every day. We create life-changing medical...Latest intelligence
- The Exhibition Hall: Past, Present and Future
- As I sit here at another pharma conference, I start to reflect on how they have changed over the years....
- Success breeds success
- This week we received the exciting news that we have been shortlisted for the Times Business Awards 2019, Tunbridge Wells in the 'Best Business 1-25 Employees' category....
- Turning learning into action: The challenge of behaviour change
- ...
Quick links
Infographics
